Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Global Biotech Ingredients Market Size Study, by Type (Active Pharmaceutical Ingredients, Biosimilars), by Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), by Expression Systems (Mammalian, Microbial, Yeast, Plant, Insect), and Regional Forecasts 2022-2032
... Insect), and Regional Forecasts 2022-2032 Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to ... Read More
-
South & Central America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The South & Central America bioprocessing market was valued at US$ 892.42 million in ... Read More
-
Middle East & Africa Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Middle East & Africa bioprocessing market was valued at US$ 314.37 million in ... Read More
-
North America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The North America bioprocessing market was valued at US$ 12,440.60 million in 2023 and is expected ... Read More
-
Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected ... Read More
-
Europe Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Europe bioprocessing market was valued at US$ 6,216.50 million in 2023 and is expected to reach ... Read More
-
Immunofluorescence Assays
... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More
-
Immunohistochemistry
... of 7.1% over the analysis period 2023-2030. Immunohistochemistry Antibodies, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Mammalian Polyclonal IgG Antibody
... 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Metabolic Markers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$532.1 Million by the ... Read More
-
Combination Antibody Therapy
... by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$215.4 Billion ... Read More
-
PEGylated Proteins
... at a CAGR of 9.1% over the analysis period 2023-2030. PEGylated Protein Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end ... Read More
-
Systemic Radiotherapy
... at a CAGR of 3.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of ... Read More
-
Global Bispecific Antibody Therapeutic Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
-
Custom Antibody
... CAGR of 9.0% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$320.3 Million by the end of the analysis ... Read More
-
Neuroscience Antibodies and Assays
... reach US$9.8 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2023-2030. Immunochemistry / Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.8% CAGR ... Read More
-
HER2 Antibodies
... at a CAGR of 7.3% over the analysis period 2023-2030. Trastuzumab, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$20.5 Billion by the end of the ... Read More
-
Plasma Protein Therapeutics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$9.3 Billion by the ... Read More
-
Immunoprecipitation
... 5.7% over the analysis period 2023-2030. Reagents Component, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$457.9 Million by the end of the analysis period. Growth ... Read More
-
Subcutaneous Immunoglobulin
... CAGR of 13.7% over the analysis period 2023-2030. Primary Immunodeficiency Diseases Application, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$12.0 Billion by the end of ... Read More
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
... Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029. Major pharmaceutical companies have ... Read More
-
Global COVID-19 Antibody Detection Kits Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had ... Read More
-
Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024 - 2030
... & New Zealand Research Antibodies Market Growth & Trends The Australia & New Zealand research antibodies market size is expected to reach USD 77.6 million by 2030, registering a CAGR of 4.8% from 2024 to ... Read More
-
North America Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
... Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) The North America antibody discovery market was valued at US$ 12,98,237.57 million in 2022 and is expected to reach US$ ... Read More
-
Europe Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
... and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) The Europe antibody discovery market was valued at US$ 8,24,441.11 million in 2022 and is expected to reach US$ 13,29,481.60 million ... Read More
-
Asia Pacific Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
... Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) The Asia Pacific antibody discovery market was valued at US$ 6,58,965.05 million in 2022 and is expected to reach US$ ... Read More
Research Assistance
